Our Company
Thoth Science’s mission is to help as many people as possible by improving qualities of life and health. Our two main projects are: Diabetes Organoid Therapy and NASH (NAFLD*) Cell Therapy. These therapies are designed to provide treatment for the patients in the ways that significantly decrease risks, costs, side effects, and overall inconveniences, while increasing their quality of lives.
* NAFLD: nonalcoholic fatty liver disease
Business Description
Thoth Science’s primary purpose is to bring effective treatments for diabetes and NASH. We have acquired several patents via technology transfers and joint R&D efforts. We suggest new, innovative, and effective solutions for the diabetes and liver diseases market. We are currently looking for partnerships and licensing agreements in the industry to help us deliver our products to the wider market.
Diabetes
“Diabetes is a chronic disease that occurs when the pancreas is no longer able to make insulin, or when the body cannot make good use of the insulin it produces.”
Thoth Science’s diabetes organoid therapy is developed to aid those suffering from these conditions. It is exercised through implanting organoids that have islet functions, which can naturally control blood glucose and be replaced yearly.
NASH
“Nonalcoholic steatohepatitis (NASH) is liver inflammation and damage caused by a buildup of fat in the liver.”
Thoth Science’s NASH Cell Therapy provides implantation of medical device containing cells that continuously release secretomes. The device is produced by inserting stem cells first into TheraCyte™, then implanted into the patients.
Coronavirus Breathalyzer
“…an Analyzer that is based on a unique combination of nanosensors that are guided to recognize and measure several selected biomarkers.”
Deep Sensing Algorithms
Thoth Science distributes DSA’s coronavirus breathalyzer product in South Korea. The breathalyzer is more efficient, cheaper, and more comfortable than the traditional swab tests and other invasive procedures. In terms of the accuracy, the device has shown above 90% sensitivity and specificity, placing it as one of the most accurate tests on the market. The technology has been developed in Finland, and now it is on its way to become available worldwide.
Click >here< to read more.